| |
| |
|
| Insider
Information: |
Epstein Robert S |
| Relationship: |
Director |
| City: |
Franklin Lakes |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
163,850 |
|
|
Indirect Shares
|
555 |
|
|
| Direct
Value |
$2,637,992 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
164,405 |
|
|
| Total
Value |
$2,637,992 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Medco Health Solutions Inc |
MHS |
Pres, Adv. Clinical S... |
2011-05-25 |
101,088 |
2011-05-25 |
555 |
Premium* |
|
|
Illumina Inc |
ILMN |
Director |
2024-05-16 |
18,306 |
2012-11-26 |
0 |
Premium* |
|
|
Veracyte, Inc. |
VCYT |
Director |
2023-06-09 |
33,125 |
2020-07-13 |
0 |
Premium* |
|
|
Fate Therapeutics Inc |
FATE |
Director |
2022-06-09 |
11,331 |
2021-06-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
123 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MHS |
Medco Health Solutions In... |
SVP Medical Affairs & CMO |
• – – |
2008-02-25 |
4 |
D |
$48.76 |
$331,275 |
D/D |
(6,794) |
145,468 |
0 |
- |
|
| MHS |
Medco Health Solutions In... |
SVP Medical Affairs & CMO |
• – – |
2008-08-08 |
4 |
AS |
$49.00 |
$967,848 |
D/D |
(19,752) |
125,716 |
0 |
- |
|
| MHS |
Medco Health Solutions In... |
SVP Medical Affairs & CMO |
• – – |
2009-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
26,840 |
152,556 |
0 |
- |
|
| MHS |
Medco Health Solutions In... |
SVP Medical Affairs & CMO |
• – – |
2009-03-03 |
4 |
D |
$38.59 |
$198,854 |
D/D |
(5,153) |
147,403 |
0 |
- |
|
| MHS |
Medco Health Solutions In... |
SVP Medical Affairs & CMO |
• – – |
2009-08-03 |
4 |
OE |
$16.26 |
$422,630 |
D/D |
26,000 |
173,403 |
0 |
- |
|
| MHS |
Medco Health Solutions In... |
SVP Medical Affairs & CMO |
• – – |
2009-08-03 |
4 |
AS |
$52.15 |
$1,969,615 |
D/D |
(37,766) |
135,637 |
0 |
- |
|
| MHS |
Medco Health Solutions In... |
SVP Medical Affairs & CMO |
• – – |
2009-11-06 |
4 |
AS |
$59.01 |
$1,784,426 |
D/D |
(30,000) |
135,637 |
0 |
- |
|
| MHS |
Medco Health Solutions In... |
SVP Medical Affairs & CMO |
• – – |
2009-11-06 |
4 |
OE |
$22.10 |
$662,850 |
D/D |
30,000 |
165,637 |
0 |
- |
|
| MHS |
Medco Health Solutions In... |
SVP Medical Affairs & CMO |
• – – |
2010-02-23 |
4 |
D |
$62.40 |
$283,046 |
D/D |
(4,536) |
131,101 |
0 |
- |
|
| MHS |
Medco Health Solutions In... |
SVP Medical Affairs & CMO |
• – – |
2010-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
26,390 |
157,491 |
0 |
- |
|
| MHS |
Medco Health Solutions In... |
SVP Medical Affairs & CMO |
• – – |
2010-03-01 |
4 |
AS |
$64.00 |
$3,292,160 |
D/D |
(51,440) |
157,491 |
0 |
- |
|
| MHS |
Medco Health Solutions In... |
SVP Medical Affairs & CMO |
• – – |
2010-03-01 |
4 |
OE |
$22.10 |
$1,393,787 |
D/D |
51,440 |
208,931 |
0 |
- |
|
| MHS |
Medco Health Solutions In... |
SVP Med & Analy Affairs & CMO |
• – – |
2010-05-25 |
4 |
D |
$55.10 |
$886,504 |
D/D |
(16,089) |
141,402 |
0 |
- |
|
| MHS |
Medco Health Solutions In... |
SVP Med & Analy Affairs & CMO |
• – – |
2010-08-31 |
4 |
D |
$43.48 |
$456,714 |
D/D |
(10,504) |
130,898 |
0 |
- |
|
| MHS |
Medco Health Solutions In... |
Pres, Adv. Clinical Science |
• – – |
2011-01-04 |
4 |
D |
$61.27 |
$738,732 |
D/D |
(12,057) |
118,841 |
0 |
- |
|
| MHS |
Medco Health Solutions In... |
Pres, Adv. Clinical Science |
• – – |
2011-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
148,841 |
0 |
- |
|
| MHS |
Medco Health Solutions In... |
Pres, Adv. Clinical Science |
• – – |
2011-03-02 |
4 |
AS |
$63.00 |
$2,224,656 |
D/D |
(35,312) |
113,529 |
0 |
- |
|
| MHS |
Medco Health Solutions In... |
Pres, Adv. Clinical Science |
• – – |
2011-05-25 |
4 |
D |
$64.35 |
$800,578 |
D/D |
(12,441) |
101,088 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
• • – |
2020-07-13 |
4 |
OE |
$5.28 |
$52,800 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
• • – |
2020-07-13 |
4 |
AS |
$28.74 |
$297,252 |
D/D |
(10,000) |
0 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2021-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
8,720 |
8,720 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2022-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
14,731 |
23,451 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Director |
– • – |
2023-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
9,674 |
33,125 |
0 |
- |
|
123 Records found
|
|
Page 5 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
